ALNYLAM
Summary
Alnylam Pharmaceuticals is an RNAi therapeutics company.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 1.60 B
Avg. Deal Size£ 1.60 B
All rights reserved. Copyright © 2025 Datasite
Summary
Alnylam Pharmaceuticals is an RNAi therapeutics company.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Christine Regan Lindenboom
Senior Vice President
Josh Brodsky
Director